期刊名称：JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
This journal is an international medium for the publication of original research reports and authoritative reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical and biomedical sciences, including relevant developments in analytical methodology, instrumentation, computation and interpretation. Applications focus on individual groups of drugs, drug stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance and drug-related topics of health and safety in the pharmaceutical industry. The journal is directed towards the needs of academic, clinical, government and industrial analysis and presents a unique forum for the discussion of current developments at the interface between pharmaceutical, biochemical and clinical analysis.
|
|
Instructions to Authors
Contributions which fulfil the Aims and Scope of the journal will be welcomed from anywhere in the world. The language of the journal is English. All manuscripts should be written in the past tense and impersonal style.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher.
Online Submission of Papers: Authors are encouraged to submit their paper online to one of the journal editors by using the Online Submission tool for the Journal of Pharmaceutical and Biomedical Analysis. To submit online authors should upload their article as a LaTeX, Microsoft?(MS) Word? WordPerfect? or PostScript via the journal's Author Gateway homepage at http://authors.elsevier.com/journal/jpba. The system generates an Adobe Acrobat PDF version of the article which is used for the reviewing process. It is crucial that all graphical and tabular elements be placed within the text, so that the file is suitable for reviewing. Authors, Reviewers and Editors send and receive all correspondence by e-mail and no paper correspondence is necessary. Authors should indicate in the covering letter in which section of the journal their paper should be published: method development, pharmaceutical applications, bioanalytical applications, or industrial applications. Manuscripts must be double-spaced on one side only, with at least 2.5 cm (1 inch) margins all round. All pages should be numbered and the first page must contain the following: title; names of all authors with their addresses in full; a running title of not more than 50 characters for use at the head of each published page.
Full instructions how to use the online submission tool are available at the online submission website of the journal.
Submission on paper: Authors who prefer to submit their manuscript by post should submit three copies of their paper and a copy of the completed Author Checklist (published on the website and in the end-pages of the Journal) to one of the Editors: Jun Haginaka, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68, Koshien Kyuban-cho Nishinomiya 663-8179, Japan, John F. Stobaugh, Department of Pharmaceutical Chemistry, 2095 Constant Avenue, University of Kansas, Lawrence, KS 66047, USA, Sergio Pinzauti, Department of Pharmaceutical Sciences, University of Florence, Via G. Capponi 9, 50121 Firenze, Italy, Ian D. Wilson, Drug Metabolism and Pharmacokinetics Department, AstraZeneca Pharmaceuticals, Mereside, Aldery Park, Macclesfield, Cheshire SK10 4TG, UK. The full name and address of the corresponding author including the telephone and fax number, as well as the E-mail address, should be listed on a separate page. Manuscripts should be type-written on good quality paper conforming to either European A4 size (210 297 mm) or US Letter size (8.5 11 inches). Manuscripts must be double-spaced on one side only, with at least 2.5 cm (1 inch) margins all round and should be submitted in triplicate. All pages should be numbered and the first page must contain the following: title, and names of all authors with their addresses in full. Figures and Tables must not be included in the body of the text.
For the initial submission of manuscripts for consideration, hard copies are sufficient. Upon revision, the electronic version and (exactly matching) printed version should be submitted together to the accepting editor (for further details see "Guide for electronic submission of manuscripts" below:
The original manuscript and figures will be discarded 1 month after publication, unless the Publisher is requested to return the original material to the author.
Peer Review: All manuscripts of original papers will be assessed by two independent Reviewers. Reviews will be assessed by one independent Reviewer. Authors will be informed of the Reviewers' comments and, where permission is given, of their identities.
Proofs: Proofs must be returned to the Publisher within the time period specified, after which the Editors reserve the right to make any necessary corrections to a paper prior to publication. Only necessary amendments will be accepted at this stage and any changes not of a typographical nature may be charged to the Author.
Reprints: Twenty-five reprints of each paper will be sent to the senior author free of charge. Additional copies may be ordered on the form accompanying the proofs.
General Considerations: A number of the commonly accepted abbreviations that may be used without further definition are described on the facing page. Any other terms to be abbreviated should first be defined and then followed immediately by the abbreviation in parentheses. Articles should be written in the past tense and in the impersonal style (I, we, me, us, etc. are to be avoided, except in the Acknowledgements section).
The following types of paper will be considered for publication:
Reviews: Authors wishing to submit a review should send a short synopsis to one of the editors before starting detailed work on a manuscript. The structure and presentation of a review article will normally be at the author's discretion. Reviews may be relatively short, i.e. dealing with a limited subject, or longer and more general in nature.
Full Length Research Papers: These papers should describe in detail original and important pieces of work in the fields covered by the Journal. Each paper should be set out as follows:
Title: This should be as brief as possible consistent with clarity. Authors' names should be given with full addresses. The name of the corresponding author, to whom reprints will be addressed, should be marked with an asterisk and the corresponding author's telephone number; fax number and email address should be indicated.
Keywords: The detailed subject index of the journal is compiled annually with the aid of keywords furnished by authors. These keywords (or key phrases) must be carefully selected to reflect the scope of the paper. General words (e.g. immunoassay, chromatography) should be avoided in favour of more specific terms (e.g. enzyme immunoassay, reversed-phase chromatography). Normally six keywords or key phrases will be sufficient.
Abstract: This should be a concise self-contained summary of the principal results of the work described, together with any essential experimental details.
Introduction: This should be a concise statement of the background to the work presented, including relevant earlier work, suitably referenced. The importance of the subject and reasons for the readers' presumed interest should be indicated.
Experimental (or Materials and Methods): This section should contain reasonably detailed accounts of materials and experimental procedures, and/or references to previously published methods used. Sufficient information should be provided to permit repetition of the work by other workers. When describing mixed solvents for chromatography, extraction or other purposes, the following convention must be adopted: solvent A-solvent B-solvent C (a:b:c, v/v/v) or (a:b:c, w/w/w) where a:b:c are the proportions (by volume or weight as appropriate) of the components A, B and C, respectively.
The method of preparation of buffers should be clearly expressed, with the pH value and molarity stated in parentheses, e.g. sodium acetate (pH 4.7; 0.1 M). For mixed solvent systems, it should be clearly stated whether the pH value quoted is the pH of the original aqueous component or the apparent pH (i.e. pH*) of the mixed solvent system. Typical examples of mobile phases employed in liquid chromatography might be:acetonitrile-sodium octylsulphate (10 mM)-sodium acetate (pH 4.7;0.1 M) (25:25:50, v/v/v), and acetonitrile-sodium octylsulphate (10 mM)-sodium acetate (0.1 M)(25:25:50, v/v/v )(pH* 4.7).
Results: The important results of the work should be clearly stated and illustrated where necessary by tables and figures. The latter should be kept to the minimum consistent with clarity. In particular figures showing linear analytical response curves are generally unnecessary, and will be deleted. The details of slope, intercept, standard error of slope, standard error of intercept, concentration range and number of standards are essential and they should be given in the text or tabulated. This section may also contain experimental detail such as that obtained when describing the development of new analytical procedures. It should include all relevant validation data, e.g. precision at defined concentrations for n replicates, limit of quantitation (if appropriate), limit of detection (if appropriate), accuracy, recovery, selectivity, specificity, robustness etc.
Discussion: The results, and their wider implications, should be fully discussed. In some cases, this section may conveniently be combined with the Results section.
Conclusions: Where appropriate, a section may be included, which concisely summarizes the principal conclusions of the work and highlights the wider implications. This section should not merely duplicate the abstract.
Acknowledgments: Where necessary, these should be given at the end of the paper.
References: References cited in the text should give inclusive page numbers. They must be definitive citations in the literature. References may include papers that have been accepted for publication and are in press. However, unpublished observations, personal communications and unpublished conference or symposium material may not be cited: these items should be referred to in the body of the text. It is important that each citation should refer to a single published work. References must be cited using numerals in brackets, e.g. [23]. Citations in the list of References at the end of the paper should be in numerical order of citation using the formats:
[23] F. Maxl, W. Slehr, J. Pharm. Biomed. Anal. 7, (1989) 211-216.
[24] K. Imai, T. Toyooka, in Selective Sample Handling and Detection in High-Performance Liquid Chromatography, Part A (R. W. Frei and K. Zech, Eds), Elsevier, Amsterdam, 1988, pp. 209-288.
Complete books should be cited as in [24] above, without the addition of page numbers, and with the editors' or authors' names first. Titles of Journals should be abbreviated according to the CASSI convention.
Tables: Should each be typed on a separate page, numbered in sequence with the body of the text. Tables should be headed with a short, descriptive caption. They should be formatted with horizontal lines only: vertical ruled lines are not required. Any annotation to the headings or to the tabulated items must be numbered and added in sequence at the foot of the table.
List of Figure Legends: A list of Figure Legends must be submitted on a separate sheet to accompany the figures. Each legend must give a concise description of the figure concerned, together with any essential experimental detail not described in the text. In particular, the key to any symbols or distinctive line formats used on the figure must be given.
Illustrations:. Provide all illustrations as high-quality printouts, suitable for reproduction (which may include reduction) without retouching. Number illustrations consecutively in the order in which they are referred to in the text. They should accompany the manuscript, but should not be included within the text. Clearly mark all illustrations on the back (or - in case of line drawings - on the lower front side) with the figure number and the author's name and, in cases of ambiguity, the correct orientation. Mark the appropriate position of a figure in the article. Ensure that each illustration has a caption. Supply captions on a separate sheet, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Line drawings should be supplied as high-quality printouts on white paper produced with black ink. The lettering and symbols, as well as other details, should have proportionate dimensions, so as not to become illegible or unclear after possible reduction; in general, the figures should be designed for a reduction factor of two to three. The degree of reduction will be determined by the Publisher. Illustrations will not be enlarged. Consider the page format of the journal when designing the illustrations. Photocopies are not suitable for reproduction. Do not use any type of shading on computer-generated illustrations. Photographs (halftones): please supply original photographs for reproduction, printed on glossy paper, very sharp and with good contrast. Remove non-essential areas of a photograph. Do not mount photographs unless they form part of a composite figure. Where necessary, insert a scale bar in the illustration (not below it), as opposed to giving a magnification factor in the legend. Note that photocopies of photographs are not acceptable. Colour illustrations: Submit colour illustrations as original photographs, high-quality computer prints or transparencies, close to the size expected in publication, or as 35 mm slides. Polaroid colour prints are not suitable. Further information concerning colour illustrations and costs is available from the Publisher.
More information on the preparation of your illustrations and information for authors submitting their article online can be found at http://www.elsevier.com/locate/authorartwork.
Short Communications: These should describe complete and original pieces of research wbose length and/or importance do not justify a full-length paper. The format is the same as that for a full-length Research Paper, except that the total number of figures and/or tables should not normally exceed six. The approximate length should be 10 pages of double-spaced type- script, including Tables and Figures, Keywords are essential. The Editors reserve the right to publish as a Short Communication a paper originally submitted as a full-length Research Paper.
Guide for the Electronic Submission of Manuscripts by post Elsevier Science publishes all manuscripts using electronic production methods. Therefore authors submitting their paper by post need to send the electronic files of their article with the hardcopy of the accepted version. Electronic files can be submitted on floppy disks, ZIP/JAZ disks, or CD ROMs. We can accept most word-processing formats (ideally Microsoft Word or WordPerfect).
To ensure fast and easy processing of floppy disk submissions, please use the following guidelines:
1. Name your files using the correct extension, e.g. Fig1.cdr, tbl1-6.xls, text.doc, fig1a.eps, fig1.tif, etc.
2. Save text and graphics on separate disks.
3. Label all disks with your name, journal to be published in, and filenames. Please also include details of the word-processing software, compression software, and platform (PC, Mac, UNIX etc) used in the creation of your files.
4. Ensure that electronic and hardcopy versions of your manuscript are identical. In cases of a discrepancy, the hardcopy version will be used as the definitive version by the production team.
For further information please visit the Author Gateway from Elsevier Science (http://www.authors.elsevier.com/journal/jpba) for the facility to track accepted articles and set up e-mail alerts to inform you when an article's status has changed. The Author Gateway also provides detailed artwork guidelines, copyright information, frequently asked questions and more.
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided when an article is accepted for publication.
Editorial Board
-
- Editors:
- Jun Haginaka, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68, Koshien Kyuban-cho, Nishinomiya 663-8179, Japan Tel: +81-798-45-9949, Fax: +81-798-41-2792, Email: jpba@ph.mwu.mukogawa-u.ac.jp
Sergio Pinzauti, Department of Pharmaceutical Sciences, University of Florence, Via G. Capponi 9, I-50121 Firenze, Italy Tel: +39-055-27-57-284, Fax: +39-055-24-07-76, Email: pinz@unifi.it
J.F. Stobaugh, Department of Pharmaceutical Chemistry, 2095 Constant Avenue, University of Kansas, Lawrence, KS 66047, USA Tel: 785-864-3996, Fax: 785-864-5736, Email: jstobaugh@sunflower.com
I.D. Wilson, Drug Metabolism and Pharmacokinetics Department, AstraZeneca Pharmaceuticals, Mereside, Aldery Park, Macclesfield, Cheshire SK10 4TG Tel: + 44 1625 513 424, Fax: + 44 1625 583 074, Email: Ian.Wilson@astrazeneca.com
- Editorial Advisory Board:
- M.G. Bartlett, Athens, GA, USA
R.G. Bell, Ozona, Fl, USA
J.P. Boehlert, Park Ridge, NJ, USA
S.R. Byrn, West Lafayette, IN, USA
V. Cavrini, Bologna, Italy
B. Chankvetadze, Münster, Germany
J. Crommen, Liège, Belgium
A.F. Fell, Bradford, UK. Joint Founding Editor
E. Gelp?/B>, Barcelona, Spain
J. Goto, Sendai, Japan
S. Görög, Budapest, Hungary
U. Holzgrabe, Würzburg, Germany
S. Honda, Higashi-Osaka, Japan
R. Kaliszan, Gdansk, Poland
P.T. Kissinger, West Lafayette, IN, USA
B. Law, Macclesfield, UK
W. Lindner, Vienna, Austria
H. Lingeman, Amsterdam, The Netherlands
C.E. Lunte, Lawrence, KS, USA
G. Mark?Varga, Lund, Sweden
B.K. Matuszewski, West Point, PA, USA
Y. Michotte, Brussels, Belgium
M.C.B.S.M. Montenegro, Porto, Portugal
D.E. Moore, Sydney, NSW, Australia
E.J. Munson, Lawrence, KS, USA
T. Nakagawa, Kyoto, Japan
J.K. Nicholson, London, UK
A. Nicolas, Naney Dedex, France
D.M. Radzik, Rochester, NY, USA
D.T. Rossi, Ann Arbour, MI, USA
T. Santa, Tokyo, Japan
A. Shibukawa, Kyoto, Japan
M.R. Smyth, Dublin, Ireland
J.T. Stewart, Athens, GA, USA
S. Terabe, Hyogo, Japan
J.-L. Veuthey, Geneva, Switzerland
S.G. Weber, Pittsburgh, PA, USA
T.J. Wozniak, Indianapolis, IN, USA
|
